Mannatech vs Natural Alternatives International
MTEX and NAII side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MTEX and NAII compare
Natural Alternatives International is the larger company, worth 3.6 times as much as Mannatech ($19.9M against $5.5M).
Natural Alternatives International grew revenue faster over the last twelve months (9.7% versus −5.0% for Mannatech).
Mannatech keeps more of each dollar of sales as profit, with a net margin of −6.9% compared with −14.5% at Natural Alternatives International.
Mannatech scores higher on the StockData Score (8 against 6 for Natural Alternatives International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MTEX | NAII |
|---|---|---|
| Size and price | ||
| Market cap | $5.5M | $19.9M |
| Share price | $2.83 | $0.901 |
| Change, 1 year | −70.5% | −71.6% |
| Change, 5 years | −92.6% | −93.1% |
| Beta (5Y) | 0.80 | 0.11 |
| Employees | 387 | 219 |
| StockData Score | ||
| Total score | 8 (better) | 6 |
| Valuation score | 2 (better) | 1 |
| Growth score | 1 | 1 |
| Performance score | 1 | 2 (better) |
| Health score | 4 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.1× (better) | 0.1× |
| P/B | – | 0.4× |
| EV/EBITDA | 0.6× | – |
| P/FCF | 3.4× | – |
| FCF yield | 29.2% (better) | −63.3% |
| Growth | ||
| Revenue growth (TTM) | −5.0% | 9.7% (better) |
| Revenue growth, 5Y average | −6.5% | −4.4% (better) |
| Profitability | ||
| Gross margin | 76.1% (better) | 6.3% |
| Operating margin | 2.5% (better) | −13.2% |
| Net margin | −6.9% (better) | −14.5% |
| FCF margin | 1.5% (better) | −8.9% |
| Return on equity | −406% | −35.0% (better) |
| Return on invested capital | – | −25.2% |
| Financial health | ||
| Debt / equity | – | 0.20 |
| Net debt / EBITDA | −0.89 | – |
| Interest coverage | 5.9× | – |
| Current ratio | 1.15 | 1.73 (better) |
| Altman Z-score | 3.83 (better) | 1.49 |
| Piotroski F-score | 2 | 2 |
| Dividends and buybacks | ||
| Buyback yield | – | 0.45% |
| Shareholder yield | 0.00% | 0.45% (better) |
| Ownership | ||
| Held by institutions | 7.9% | 10.5% |
| Held by insiders | – | 5.0% |
| Insider net buying, 12 months | $62.2K (better) | $26.8K |
| Short interest, % of float | – | 0.03% |
Go deeper
- MTEX stock overview
- MTEX income statement
- MTEX valuation and score
- NAII stock overview
- NAII income statement
- NAII valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.